vip924
vincerx pharma
['vip924', 'vincerx']
$vinc press release vincerx pharma presents preclinical data on vip924, a first-in-class antibody-drug conjugate (adc), at the 2023 american association for cancer research (aacr) annual meeting read the explanation, based on ai opinion 
Instant stock market news and events with social tools 👇

🚀 https://t.co/eHUJAheGEZ
📱Tradesense in AppStore/Google Play

Service analyzes big data from press & markets